T-siHER2-NP(PDX Pharmaceuticals)

N/A

Report date: 2026/01/27 16:05:19

Base Information

Drug NameT-siHER2-NP(PDX Pharmaceuticals)

Drug Alias NameNanoparticle loaded with trastuzumab and siRNA(PDX Pharmaceuticals)T-siHER2-NP™

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodySmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA

Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonists

TargetsReceptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsYes

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPdx Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesPdx Pharmaceuticals Inc

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A